摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-dimethylpyrazole-4-sulfonohydrazide | 80466-94-0

中文名称
——
中文别名
——
英文名称
3,5-dimethylpyrazole-4-sulfonohydrazide
英文别名
3,5-dimethyl-1H-pyrazole-4-sulfonohydrazide
3,5-dimethylpyrazole-4-sulfonohydrazide化学式
CAS
80466-94-0
化学式
C5H10N4O2S
mdl
——
分子量
190.226
InChiKey
ACALHRXQSFZNTR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    109
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    CREMLYN, R. J.;SWINBOURNE, F. J.;YUNG, KIN-MAN, J. HETEROCYCL. CHEM., 1981, 18, N 5, 997-1006
    摘要:
    DOI:
  • 作为产物:
    描述:
    3,5-二甲基-1H-吡唑-4-磺酰氯一水合肼 作用下, 以70%的产率得到3,5-dimethylpyrazole-4-sulfonohydrazide
    参考文献:
    名称:
    Cremlyn, Richard J.; Swinbourne, Fred J.; Yung, Kin-Man, Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 997 - 1006
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Development of novel NLRP3-XOD dual inhibitors for the treatment of gout
    作者:Weiwei Wang、Jing Pang、Eun Hee Ha、Mengze Zhou、Zhubin Li、Sheng Tian、Huanqiu Li、Qinghua Hu
    DOI:10.1016/j.bmcl.2019.126944
    日期:2020.2
    Gout is a crystalline-related arthropathy caused by the deposition of monosodium urate (MSU). Acute gouty arthritis is the most common first symptom of gout. Studies have shown that NOD-like receptor protein 3 (NLRP3) inflammasome as pattern recognition receptors can be activated by uric acid crystallization, triggering immune inflammation and causing acute gouty arthritis symptoms. Currently, the treatment of gout mainly includes two basic methods: reducing uric acid and alleviating inflammation. In this paper, 22 novel benzoxazole and benzimidazole derivatives were synthesized from deoxybenzoin oxime derivatives. These compounds have good inhibitory effects on NLRP3 and XOD screened by our research group in the early stage. The inhibitory activities of XOD and NLRP3 and their derivatives were also screened. Notably, compound 9b is a multi-targeting inhibitor of NLRP3 and XOD with excellent potency in treating hyperuricemia and acute gouty arthritis.
  • Cremlyn, Richard J.; Swinbourne, Fred J.; Yung, Kin-Man, Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 997 - 1006
    作者:Cremlyn, Richard J.、Swinbourne, Fred J.、Yung, Kin-Man
    DOI:——
    日期:——
  • CREMLYN, R. J.;SWINBOURNE, F. J.;YUNG, KIN-MAN, J. HETEROCYCL. CHEM., 1981, 18, N 5, 997-1006
    作者:CREMLYN, R. J.、SWINBOURNE, F. J.、YUNG, KIN-MAN
    DOI:——
    日期:——
查看更多